Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424 Conference

Fisher, Barbara J, Pugh, Stephanie L, Macdonald, David R et al. (2020). Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424 . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 107(4), 720-725. 10.1016/j.ijrobp.2020.03.027

Open Access International Collaboration

cited authors

  • Fisher, Barbara J; Pugh, Stephanie L; Macdonald, David R; Chakravatri, Arnab; Lesser, Glenn J; Fox, Sherry; Rogers, C Leland; Werner-Wasik, Maria; Doyle, Thomas; Bahary, Jean-Paul; Fiveash, John B; Bovi, Joseph A; Howard, Steven P; Yu, Hsiang-Hsuan Michael; D'Souza, David; Laack, Nadia N; Barani, Igor J; Kwok, Young; Wahl, Daniel R; Strasser, Jon F; Won, Minhee; Mehta, Minesh P

sustainable development goals

authors

publication date

  • July 15, 2020

published in

keywords

  • ADULTS
  • CANCER EORTC
  • EFFICACY
  • EORTC PROGNOSTIC-FACTORS
  • EUROPEAN ORGANIZATION
  • Life Sciences & Biomedicine
  • MODELS
  • Oncology
  • RADIOTHERAPY
  • RANDOMIZED-TRIAL
  • Radiology, Nuclear Medicine & Medical Imaging
  • SURVIVAL
  • Science & Technology
  • VALIDATION

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 720

end page

  • 725

volume

  • 107

issue

  • 4